These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22339134)

  • 1. Block copolymer-based gadolinium nanoparticles as MRI contrast agents with high T1 relaxivity.
    Hou S; Tong S; Zhou J; Bao G
    Nanomedicine (Lond); 2012 Feb; 7(2):211-8. PubMed ID: 22339134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
    Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
    Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
    Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbium-doped gadolinium oxide nanoparticles prepared by laser ablation in liquid for use as a fluorescence and magnetic resonance imaging dual-modal contrast agent.
    Chen F; Chen M; Yang C; Liu J; Luo N; Yang G; Chen D; Li L
    Phys Chem Chem Phys; 2015 Jan; 17(2):1189-96. PubMed ID: 25418675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyano-bridged coordination polymer nanoparticles with high nuclear relaxivity: toward new contrast agents for MRI.
    Guari Y; Larionova J; Corti M; Lascialfari A; Marinone M; Poletti G; Molvinger K; Guérin C
    Dalton Trans; 2008 Jul; (28):3658-60. PubMed ID: 18615211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium contrast agent selection and optimal use for body MR imaging.
    Guglielmo FF; Mitchell DG; Gupta S
    Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Europium-doped gadolinium sulfide nanoparticles as a dual-mode imaging agent for T1-weighted MR and photoluminescence imaging.
    Jung J; Kim MA; Cho JH; Lee SJ; Yang I; Cho J; Kim SK; Lee C; Park JK
    Biomaterials; 2012 Aug; 33(24):5865-74. PubMed ID: 22617320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
    ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
    Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
    Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors.
    Rigaux G; Roullin VG; Cadiou C; Portefaix C; Van Gulick L; Bœuf G; Andry MC; Hoeffel C; Vander Elst L; Laurent S; Muller R; Molinari M; Chuburu F
    Nanotechnology; 2014 Nov; 25(44):445103. PubMed ID: 25325295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: manipulation of particle size and magnetic resonance imaging capability.
    Hatakeyama W; Sanchez TJ; Rowe MD; Serkova NJ; Liberatore MW; Boyes SG
    ACS Appl Mater Interfaces; 2011 May; 3(5):1502-10. PubMed ID: 21456529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
    Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
    Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.